Polymer Biodegradability: Hydrolysis of Polyesters & Polyamides | IB Chemistry

Bioplastics are evaluated by two criteria: origin (biosourced from plants/animals) and end-of-life behavior (biodegradability). A material can be biosourced but not biodegradable, or petroleum-based but biodegradable. Life Cycle Assessment (ACV) is essential to evaluate true environmental impact, considering all resources and waste generated. PLA (polylactic acid) from corn starch is biosourced but contaminates PET recycling streams. Even biosourced materials can have hidden impacts—producing PLA bottles requires tractors, pesticides, and soil depletion. This demonstrates that 'greenwashing' can occur when materials appear environmentally friendly but have hidden environmental costs.

Conventional plastics require between 100 to 1000 years to fully degrade in the environment. In contrast, properly designed bioplastics can degrade in less than one year under appropriate conditions. This dramatic reduction in degradation time represents a significant environmental advantage of bioplastics over traditional petroleum-based plastics.

Bio-based plastics are not automatically biodegradable—chemistry determines degradation potential. Both petroleum and bio-based materials can create identical non-degradable polyethylene structures. About 45% of bioplastics are non-biodegradable, behaving identically to conventional plastics. Compostable plastics like PLA require industrial facilities (3 months) and won't degrade otherwise. Crop-based bioplastics demand enormous land and water resources—replacing all plastic packaging would need over half the world's corn production. Consumer awareness of production inputs remains limited.

Conventional synthetic plastics take extremely long timeframes to degrade, ranging from 50 to 100 years or even longer. Natural bioplastics degrade much faster because they originate from plant materials that microorganisms can more easily break down. This significant difference in degradation rates is one of the key advantages of bioplastics over traditional plastics.

ADB conducted life cycle assessments comparing six bioplastic resins against traditional and recycled petrochemical plastics, measuring greenhouse gas emissions, PM emissions, agricultural land use, water use, and eutrophication. Key findings show bioplastics offer lower fossil resource use but increase PM emissions and agricultural land requirements. End-of-life management is critical—improper disposal converts carbon to methane (higher GHG potential). Cost competitiveness depends on oil markets. Bioplastics are most suitable for difficult-to-recycle applications like food contact packaging. Thailand produces 10 million metric tons of sugar annually, with less than 1% currently used for bioplastics, indicating sufficient feedstock availability for scaling.

Biodegradable polymers are essential for biomedical applications including tissue engineering scaffolds and drug delivery. Key examples include polyactic acid, polyglycolic acid, and their copolymers (PLGA), which are natural polyesters. These polymers can be synthesized for 3D porous scaffolds and controlled drug release. Polyglycolide is commercially available as resorbable sutures (Dexon). Polylactic acid and polylactide are used for sutures, bone fixation screws, and tissue engineering scaffolds. Polycaprolactone, though expensive, is used for drug delivery and vaccine vehicles. Bacterial polyesters like polyhydroxybutyrate can be formed into films, fibers, and bone pins. Hydrolytically degradable polymers include polyurethanes, polyester amides, and polyanhydrides.

Biodegradable polymers have critical biomedical applications: (1) Absorbable sutures made from polyglycolic acid, polylactic acid, and their copolymers replace traditional non-absorbable sutures, eliminating the need for removal surgery, (2) Bone fixation devices use polyglycolic acid, polylactic acid, and polydioxanone, (3) Vascular grafts use crosslinked gelatin-heparin complexes, (4) Artificial skin uses collagen, chitin, and polylactic acid, and (5) Drug delivery systems use polylactic acid and polyesters for controlled release.

Degradable polymers include polyesters, polyamides, polycarbonates, and poly(anhydrides), with natural materials like collagen degrading faster than synthetic versions. Key examples include polyglycolic acid (first biodegradable suture, 50% crystallinity), polylactic acid enantiomers (PLLA/PDLA with different water stability), and PLGA copolymers (rapid degradation for sutures and drug delivery). Polycaprolactone offers slow degradation with high drug permeability. These materials enable controlled drug release, tissue scaffolds, and applications ranging from sutures to fracture fixation. The degradation products typically enter metabolic cycles like the Krebs cycle, producing CO2 and water.

Three major polyester polymers are widely used in biomedical applications: Poly(lactic acid) (PLA), Poly(glycolic acid) (PGA), and Poly(lactic-co-glycolic acid) (PLGA). These polymers are FDA-approved and extensively utilized for drug and gene delivery systems as well as tissue engineering scaffolds. Upon degradation, these polymers break down into lactic acid and glycolic acid monomers, which are metabolized by the body into carbon dioxide and water. Their widespread clinical adoption demonstrates their established safety profile and effectiveness for controlled release applications.

Biodegradable polyesters made from lactic acid have important medical applications, such as surgical stitches and internal sutures. After the incision heals, the body's bacteria and microorganisms naturally break down the polyester material, eliminating the need for additional surgery to remove the stitches. This makes biodegradable polyesters valuable for temporary medical applications.

Degradation rates in biodegradable polymers can be controlled through copolymerization. Using copolymers with different monomer ratios allows adjustment of degradation speed: increasing polycaprolactone content accelerates degradation, while increasing glycolic acid content slows it. Polymer coatings on titanium implants can be used for controlled release of bioactive drugs. Composite devices can be designed to permit mechanical loads in certain directions while restricting others, enabling sophisticated control over implant behavior.

The rate of biodegradation of polymers is controlled by three key factors: (1) Crystallinity percentage - higher crystallinity provides greater strength to the polymer but slows down the degradation rate; (2) Molecular weight - polymers with molecular weights up to 20,000 maintain their physical and mechanical properties, but beyond this point, degradation accelerates as monomers begin to break away; (3) Hydrophobicity - more hydrophobic polymers resist water absorption and are less susceptible to biodegradation.

To maintain the required molecular weight for polymer usefulness, manufacturers incorporate additives to reduce degradation rates. Two main approaches exist: (1) Adding another polymer molecule as an adjective to the polymer of interest, called polymer blending, which is a cost-effective method for achieving engineering thermoplastics; (2) Adding small organic or inorganic molecules as plasticizing additives. Stabilization involves identifying the weak link and substituting the point of failure with another chemical moiety having a lower rate of degradation.

The rate of hydrolytic degradation in polymers is controlled by multiple interconnected factors including bond stability (with ester and anhydride bonds degrading faster than amide bonds), hydrophobicity/hydrophilicity (hydrophilic materials degrade faster), molecular weight (higher molecular weight slows degradation), crystallinity (higher crystallinity reduces degradation rate), porosity (increased porosity accelerates degradation), and glass transition temperature (lower Tg above which polymer motion increases hydrolysis). Synthetic polymers like aliphatic polyesters (PLA, PGA) and poly anhydrides offer tunable degradation rates for controlled drug delivery, while natural polymers are often preferred for tissue engineering applications.

Four key polymer properties control degradation rates: (1) Enthalpy of melting indicates crystallinity; (2) Molecular weight affects chain flexibility; (3) Glass transition temperature reflects amorphous fraction; (4) Hydrophobicity determines water interaction potential. Crystallinity benefits physical properties but slows degradation, while hydrophobicity resists water uptake necessary for hydrolysis.